Literature DB >> 9365365

Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes.

P F Chinnery1, N Howell, R N Lightowlers, D M Turnbull.   

Abstract

Many patients with inherited mitochondrial encephalopathies have one of two pathogenic mutations of mitochondrial DNA (mtDNA): A3243G or A8344G. Individuals who harbour these mutations carry both mutant and wild-type alleles within each cell (heteroplasmy). Despite clear evidence of a direct relationship between the level of mutation and mitochondrial respiratory chain function in vitro, it has been more difficult to demonstrate a clear correlation between clinical phenotype and the level of mutant mtDNA in vivo. To address this issue, we identified 245 individuals who carry either the A3243G or A8344G mutations, and studied the relationship between the incidence of specific clinical features and the level of mutant mtDNA in blood (for A3243G, n = 73; for A8344G, n = 25) and/or skeletal muscle (for A3234G, n = 111; for A8344G, n = 55). Within this study group, the frequency of key clinical features was significantly different for individuals harbouring the A3243G and A8344G mutations. For both mutations, there was a correlation between the frequency of the more common clinical features and the level of mutant mtDNA in muscle. In contrast, we did not observe a correlation between the frequency of clinical features and the level of mutant mtDNA in blood. Therefore, measurement of the level of the A3243G and A8344G mutations in muscle will allow the identification of individuals who are at risk of developing specific complications, thus improving the prognostic advice that can be given to patients and family members who carry these mutations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365365     DOI: 10.1093/brain/120.10.1713

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  87 in total

1.  Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993.

Authors:  S L White; V R Collins; R Wolfe; M A Cleary; S Shanske; S DiMauro; H H Dahl; D R Thorburn
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  The biology of mitochondrial disease.

Authors:  A Clarke
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

Review 3.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

Review 4.  Mitochondria.

Authors:  P F Chinnery; E A Schon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

5.  Simultaneous A8344G heteroplasmy and mitochondrial DNA copy number quantification in myoclonus epilepsy and ragged-red fibers (MERRF) syndrome by a multiplex molecular beacon based real-time fluorescence PCR.

Authors:  K Szuhai; J Ouweland; R Dirks; M Lemaître; J Truffert; G Janssen; H Tanke; E Holme; J Maassen; A Raap
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

6.  Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation.

Authors:  Angela Pyle; Robert W Taylor; Steve E Durham; Marcus Deschauer; Andrew M Schaefer; David C Samuels; Patrick F Chinnery
Journal:  J Med Genet       Date:  2006-09-01       Impact factor: 6.318

7.  Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA.

Authors:  Chih-Ming Lin; Peterus Thajeb
Journal:  Metab Brain Dis       Date:  2007-01-17       Impact factor: 3.584

8.  The development of novel quantification assay for mitochondrial DNA heteroplasmy aimed at preimplantation genetic diagnosis of Leigh encephalopathy.

Authors:  Hiroto Tajima; Kou Sueoka; Sung Yung Moon; Akira Nakabayashi; Tomoyoshi Sakurai; Yukitaka Murakoshi; Hiroyoshi Watanabe; Soukichi Iwata; Tsuyoshi Hashiba; Shingo Kato; Yu-Ichi Goto; Yasunori Yoshimura
Journal:  J Assist Reprod Genet       Date:  2007-03-08       Impact factor: 3.412

9.  A8344G tRNALys mutation associated with recurrent brain stem stroke-like episodes.

Authors:  Ioannis Zaganas; Helen Latsoudis; Eufrosini Papadaki; Pelagia Vorgia; Martha Spilioti; Andreas Plaitakis
Journal:  J Neurol       Date:  2009-02-27       Impact factor: 4.849

10.  The typical MERRF (A8344G) mutation of the mitochondrial DNA associated with depressive mood disorders.

Authors:  Mari Judit Molnar; Jozsef Perenyi; Eva Siska; George Nemeth; Zoltan Nagy
Journal:  J Neurol       Date:  2009-03-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.